| For: | Sun HJ, Jiao B, Wang Y, Zhang YH, Chen G, Wang ZX, Zhao H, Xie Q, Song XH. Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions. World J Gastroenterol 2024; 30(14): 1968-1981 [PMID: 38681120 DOI: 10.3748/wjg.v30.i14.1968] | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i14/1968.htm | 
| Number | Citing Articles | 
| 1 | 
                             
                                            Yidong Jin, Han Zhang, Min Zhou, Shaojun Zhang, Mi Guo. Alteration of Serum MLKL Levels and Their Association with Severity and Clinical Outcomes in Human Severe Traumatic Brain Injury: A Prospective Cohort Study. International Journal of General Medicine 2024; : 5069 doi: 10.2147/IJGM.S485153
                                         
                                     | 
                    
| 2 | 
                             
                                            Chunfeng Lu, Yu Zhang, Jingrong Miao, Wei Wei, Yang Wang, Yiwen Han, Yuanyuan Li, Ye Tong, Tianle Wang, Xiaofeng Bao. Inhibition of ZFP281/ZNF281–RIPK1/RIPK3/MLKL signaling in hepatocytes by pterostilbene relieves hepatic lipometabolic disorder and inflammation in non-alcoholic steatohepatitis. International Immunopharmacology 2025; 146: 113936 doi: 10.1016/j.intimp.2024.113936
                                         
                                     | 
                    
| 3 | 
                             
                                            Zhuoheng Li, Juan Li, Shuli He, Jun Chen, Chengjun Deng, Jintao Duan. Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model. Food Science & Nutrition 2025; 13(1) doi: 10.1002/fsn3.4694
                                         
                                     | 
                    
| 4 | 
                             
                                            Han-Ning Xuan Yuan, Hyun Sung Kim, Gye Ryeol Park, Jae Eun Ryu, Ji Eun Kim, In Young Kang, Hye Young Kim, Seung Min Lee, Ju Hee Oh, Eileen L Yoon, Dae Won Jun. Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease <i>via</i> necroptosis-independent pathway. World Journal of Gastroenterology 2025; 31(6): 96782 doi: 10.3748/wjg.v31.i6.96782
                                         
                                            
                                     | 
                    
| 5 | 
                             
                                            Marwa Matboli, Maha Saad, Manar Fouad Ahmed, Amany Helmy Hasanin, Ghada M. Ellithy, Marian Samir Abdelwahab, Eman Hamdy Badr Eltantawy, Ghada Galal Hamam, Amany E. Hamoud, Marwa M. El-Shafei, Nehal samir. Febuxostat alleviate metabolic dysfunction-associated steatohepatitis in rat model via targeting inflammation, cell death, and intestinal barrier dysfunction. Biomedicine & Pharmacotherapy 2025; 187: 118086 doi: 10.1016/j.biopha.2025.118086
                                         
                                     | 
                    
| 6 | 
                             
                                            Jianxin Xi, Shuangyin Lei, Jie Chen, Jiahui Liu, Chenhao Shan, Xun Sun, Qianqian Zheng, Xiaoju Shi. Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02558-x
                                         
                                     | 
                    
| 7 | 
                             
                                            Hui-li Xu, Sheng-rong Wan, Ying An, Qi Wu, Yi-hang Xing, Chen-hao Deng, Ping-ping Zhang, Yang Long, Bu-tuo Xu, Zong-zhe Jiang. Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discovery 2024; 10(1) doi: 10.1038/s41420-024-02168-z
                                         
                                     | 
                    
